9-87727672-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001912.5(CTSL):c.69C>A(p.His23Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00021 in 1,613,840 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001912.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTSL | NM_001912.5 | c.69C>A | p.His23Gln | missense_variant | 2/8 | ENST00000343150.10 | NP_001903.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTSL | ENST00000343150.10 | c.69C>A | p.His23Gln | missense_variant | 2/8 | 1 | NM_001912.5 | ENSP00000345344.5 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000402 AC: 101AN: 251480Hom.: 0 AF XY: 0.000361 AC XY: 49AN XY: 135918
GnomAD4 exome AF: 0.000207 AC: 302AN: 1461790Hom.: 1 Cov.: 31 AF XY: 0.000205 AC XY: 149AN XY: 727202
GnomAD4 genome AF: 0.000243 AC: 37AN: 152050Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74260
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.69C>A (p.H23Q) alteration is located in exon 2 (coding exon 1) of the CTSL gene. This alteration results from a C to A substitution at nucleotide position 69, causing the histidine (H) at amino acid position 23 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at